Author:
Noorda E. M.,Vrouenraets B. C.,Nieweg O. E.,van Geel A. N.,Eggermont A. M. M.,Kroon B. B. R.
Publisher
Springer Science and Business Media LLC
Reference30 articles.
1. Vrouenraets BC, Nieweg OE, Kroon BBR. Thirty-five years of isolated limb perfusion for melanoma: indications and results.Br J Surg 1996;83:1319–28.
2. Eggermont AMM, Schraffordt Koops H, Kroon BBR, et al. Isolated limb perfusion with high-dose tumor necrosis factor-alpha in combination with interferon-gamma and melphalan for nonresectable extremity soft tissue sarcomas: a multicenter trial.J Clin Oncol 1996;14:2653–65.
3. Fraker DL, Alexander HR, Andrich M, Rosenberg SA. Treatment of patients with melanoma of the extremity using hyperthermic isolated limb perfusion with melphalan, tumor necrosis factor, and interferon gamma: results of a tumor necrosis factor dose-escalation study.J Clin Oncol 1996;14:479–89.
4. Fraker DL, Alexander HR, Andrich M, et al. Palliation of regional symptoms of advanced extremity melanoma by isolated limb perfusion with melphalan and high-dose tumor necrosis factor.Cancer J Sci Am 1995;1:122.
5. Bartlett DL, Grace M, Alexander HR, Libutti SK, Fraker DL. Isolated limb perfusion with tumor necrosis factor and melphalan in patients with extremity melanoma after failure of isolated limb perfusion with chemotherapeutics.Cancer 1997;80:2084–90.
Cited by
51 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献